ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Up 14.0% in January

ICU Medical, Inc. (NASDAQ:ICUI) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 838,100 shares, a growth of 14.0% from the December 31st total of 735,400 shares. Currently, 3.7% of the shares of the stock are short sold. Based on an average daily volume of 217,900 shares, the short-interest ratio is currently 3.8 days.

ICU Medical Stock Down 0.9 %

NASDAQ:ICUI opened at $164.36 on Monday. ICU Medical has a one year low of $86.80 and a one year high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The company has a market cap of $4.02 billion, a PE ratio of -35.96 and a beta of 0.63. The firm’s 50 day simple moving average is $160.98 and its 200 day simple moving average is $162.52.

Analyst Ratings Changes

Several research analysts have commented on ICUI shares. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp boosted their target price on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $199.67.

Insider Buying and Selling

In related news, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,737 shares of company stock worth $2,879,752. Company insiders own 6.70% of the company’s stock.

Institutional Trading of ICU Medical

Several institutional investors have recently modified their holdings of ICUI. State Street Corp raised its position in ICU Medical by 9.3% during the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after purchasing an additional 77,506 shares during the last quarter. Geode Capital Management LLC raised its position in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after acquiring an additional 48,106 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of ICU Medical by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after acquiring an additional 27,927 shares during the period. WCM Investment Management LLC boosted its holdings in ICU Medical by 1.3% in the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier’s stock valued at $45,272,000 after acquiring an additional 3,407 shares during the last quarter. Finally, Victory Capital Management Inc. increased its position in ICU Medical by 0.5% during the 3rd quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier’s stock valued at $25,973,000 after purchasing an additional 687 shares during the period. Institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.